Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses

Mariah Coakley From the Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843 (Coakley, Peck, Taylor, Matthews); and the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163 (Mealey).

Search for other papers by Mariah Coakley in
Current site
Google Scholar
PubMed
Close
 BA
,
Kenneth E. Peck From the Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843 (Coakley, Peck, Taylor, Matthews); and the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163 (Mealey).

Search for other papers by Kenneth E. Peck in
Current site
Google Scholar
PubMed
Close
 MS
,
Tex S. Taylor From the Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843 (Coakley, Peck, Taylor, Matthews); and the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163 (Mealey).

Search for other papers by Tex S. Taylor in
Current site
Google Scholar
PubMed
Close
 DVM
,
Nora S. Matthews From the Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843 (Coakley, Peck, Taylor, Matthews); and the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163 (Mealey).

Search for other papers by Nora S. Matthews in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Katrina L. Mealey From the Texas Veterinary Medical Center, Texas A & M University, College Station, TX 77843 (Coakley, Peck, Taylor, Matthews); and the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99163 (Mealey).

Search for other papers by Katrina L. Mealey in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective

To compare serum disposition of flunixin meglumine after IV administration of a bolus to horses, donkeys, and mules.

Animals

3 clinically normal horses, 5 clinically normal donkeys, and 5 clinically normal mules.

Procedure

Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after IV administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight). Serum was analyzed in duplicate by the use of high-performance liquid chromatography for determination of flunixin meglumine concentrations. The serum concentration-time curve for each horse, donkey, and mule were analyzed separately to estimate noncompartmental pharmacokinetic variables

Results

Mean (± SD) area under the curve for donkeys (646 ± 148 minute • µg/ml) was significantly less than for horses (976 ± 168 minute • μg/ml) or for mules (860 ± 343 minute • µg/ml). Mean residence time for donkeys (54.6 ± 7 minutes) was significantly less than for horses (110 ± 24 minutes) or for mules (93 ± 30 minutes). Mean total body clearance for donkeys (1.78 ± 0.5 ml/kg/h) was significantly different from that for horses (1.14 ± 0.18 ml/kg/h) but not from that for mules (1.4 ± 0.5 ml/kg/h). Significant differences were not found between horses and mules for any pharmacokinetic variable.

Conclusion and Clinical Relevance

Significant differences exist with regard to serum disposition of flunixin meglumine in donkeys, compared with that for horses and mules. Consequently, flunixin meglumine dosing regimens used in horses may be inappropriate for use in donkeys. (Am J Vet Res 1999;60:1441–1444)

Abstract

Objective

To compare serum disposition of flunixin meglumine after IV administration of a bolus to horses, donkeys, and mules.

Animals

3 clinically normal horses, 5 clinically normal donkeys, and 5 clinically normal mules.

Procedure

Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after IV administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight). Serum was analyzed in duplicate by the use of high-performance liquid chromatography for determination of flunixin meglumine concentrations. The serum concentration-time curve for each horse, donkey, and mule were analyzed separately to estimate noncompartmental pharmacokinetic variables

Results

Mean (± SD) area under the curve for donkeys (646 ± 148 minute • µg/ml) was significantly less than for horses (976 ± 168 minute • μg/ml) or for mules (860 ± 343 minute • µg/ml). Mean residence time for donkeys (54.6 ± 7 minutes) was significantly less than for horses (110 ± 24 minutes) or for mules (93 ± 30 minutes). Mean total body clearance for donkeys (1.78 ± 0.5 ml/kg/h) was significantly different from that for horses (1.14 ± 0.18 ml/kg/h) but not from that for mules (1.4 ± 0.5 ml/kg/h). Significant differences were not found between horses and mules for any pharmacokinetic variable.

Conclusion and Clinical Relevance

Significant differences exist with regard to serum disposition of flunixin meglumine in donkeys, compared with that for horses and mules. Consequently, flunixin meglumine dosing regimens used in horses may be inappropriate for use in donkeys. (Am J Vet Res 1999;60:1441–1444)

Advertisement